CRWV · CoreWeave, Inc.

Current Thesis

The Q1 beat-and-fade is fully behind the name, and the second act has a flow catalyst the engine can date: Nasdaq-100 inclusion effective 2026-06-22, announced 6/12 alongside Astera Labs and Nebius. The stock soared into the close that Friday on the news forced passive buying plus a re-rating impulse. Underneath the index event, the central bear pillar is weakening: on 6/11 CoreWeave priced $3.5B of senior notes due 2032 ($1.25B + €2B) explicitly to repay existing indebtedness, the first refinancing that addresses the expensive 9.750% 2031 paper the "credit-won't-ratify" thesis was built on. The next earnings print is 2026-08-11, so there is no binary overhang in the window. The offsetting facts are loud: Jim Chanos went public short on 6/10, flagging $2.3B of insider sales since IPO, CRWV remains the laggard of its own theme, and the run-up into 6/22 carries genuine buy-the-rumor/sell-the-news risk. Improving setup that has reclaimed momentum into a dated catalyst, but with a famous short and persistent insider supply bolted to it a medium-conviction continuation, not a clean fat pitch.

Bull Case

• 2026-06-12: CoreWeave joins the Nasdaq-100 effective 2026-06-22 (added with Astera Labs and Nebius); the stock jumped Friday on forced index/passive demand and the re-rating signal. First mechanical, non-narrative buyer base for the name.
• 2026-06-11: Cantor Fitzgerald reiterates Overweight, $167 PT desk support held through the recovery, stacking on BNP Paribas Outperform $192 (6/2), Citi $158, Jefferies $160.
• 2026-06-11: Priced $3.5B 2032 senior notes ($1.25B + €2B) to repay outstanding debt terming out and refinancing the 9.750% stack; if the new coupon prints inside the 2031s, credit is finally ratifying the equity bid.
• 2026-06-06: SpaceX signs a $920M/month AI deal with Google locking 110,000 NVIDIA GPUs through 2029 the hyperscale GPU-rental tape CRWV sells into is still accelerating.
• 2026-06-01: CoreWeave completes industry-first validation of NVIDIA Vera Rubin NVL72 and brings it up on CoreWeave Cloud first-to-deploy on next-gen silicon, the original moat intact.
• 2026-05-07 (Q1): Revenue $2.08B (+112% YoY), adj. EBITDA $1.2B (+91%), $99.4B backlog / 3.5 GW contracted power, 2026 guide held at $12–$13B. Top-line hyper-growth uninterrupted.
• 2026-05-21: NVIDIA holds ~47.2M shares (~$1.9B opened position) the supplier is also a top holder, a structural backstop for its own ecosystem.

Bear Case

• 2026-06-10: Jim Chanos publicly short, citing $2.3B of insider stock sales since the IPO a named short with a thesis, plus confirmation that post-lockup supply is still hitting the tape into strength.
• 2026-05-07: Q2 guide came in light ($2.53B mid vs $2.69B consensus) with capex raised to $31–$35B. For a stock priced on acceleration, management owning a marginal guide-down is the structurally worst signal, and it is why CRWV led the theme lower into the $104 print low.
• Relative strength: CRWV remains the post-print laggard of gpu-cloud-neoclouds. NVDA, IREN ($1.6B Dell/Blackwell deal 5/27) and Core Scientific led off the print while CRWV mean-reverted; a momentum book defaults to the leader.
• Funding stack: even after the 6/11 refi, the balance sheet carries the 9.750% 2031s, an $850M CoreWeave-tied data-center junk bond (6/1) and a multibillion loan stack on a ~$25B debt load. The new notes are a refinancing, not a deleveraging interest burden stays heavy.
• 2026-05-18 / live: DA Davidson cut Buy ($175) → Neutral ($100) and Bernstein Underperform $67 is still on the board, ~35–50% below the recovery zone if the base fails. Customer concentration (Microsoft/Meta) and hyperscaler in-sourcing (Maia/MTIA) are unchanged structural risks.
• Index-event mechanics: forced 6/22 buying frequently front-runs into the effective date and unwinds after; a stock that has already soared on the announcement can give it all back once passive demand clears.

Setup & Price Structure

The damage and the repair are both well-defined. The April parabola topped in the mid-$130s, the Q1 fade bottomed at a ~$104 post-print low (2026-05-20), and the tape spent late May building a base off that level. The 6/12 Nasdaq-100 announcement was the breakout trigger a sharp Friday advance on volume that argues for a 20-EMA reclaim and a higher low above $104. That structure is the upgrade condition that had been missing: a confirmed higher-low with CRWV outperforming NBIS/NVDA rather than lagging. Resistance is the unfilled mid-$130s April-peak shelf; below, the air pocket runs $104 → DA Davidson $100 → Bernstein $67 if the base breaks. The street is wide Bernstein $67 to BNP $192 so realized direction will be set by whether the index bid and credit refi convert the base into trend, or whether the 6/22 event marks a local top. Treat strength above the reclaimed 20-EMA as confirmation; treat a weekly close back under $104 as the base failing.

Catalyst Calendar (next 30 days)

• 2026-06-22: Nasdaq-100 inclusion effective index funds rebalance; forced passive buying, with sell-the-news risk once the flow clears.
• ~2026-06-16 to 06-20 (est.): SpaceX IPO debut week Cramer (6/13) frames it as a potential trigger for a wave of AI deals; sympathy/sentiment driver for high-beta AI-infra names including CRWV.
• ~late June (est.): settlement and use-of-proceeds on the $3.5B 2032 senior notes watch the realized coupon/spread versus the 9.750% 2031s as a real-time credit verdict on the equity recovery.
• Ongoing: post-lockup Form 144/4 insider-sale filings Chanos flagged $2.3B of cumulative sales; large prints into strength would cap the rally.
• 2026-08-11: Q2 earnings (outside the 30-day window) the next binary; no earnings overhang until the blackout opens ~early August.

What Would Change Our Mind

Confirms the long continuation: a weekly close holding above the reclaimed 20-EMA with a clean higher low above $104, CRWV outperforming NBIS and NVDA through the 6/22 inclusion, and the new 2032 notes pricing/trading inside the 9.750% 2031s (credit ratifying). That combination upgrades the read toward high conviction. Breaks the thesis: a weekly close below the ~$104 post-Q1 low (base failed, $100/$67 air pocket opens); the 2032 notes pricing wider than the 9.750% paper (credit refusing the recovery); CRWV failing to hold the 20-EMA through the 6/22 inclusion so the index-flow leg is spent with nothing behind it; or a fresh cluster of large insider Form 4 sales into the rally validating the Chanos supply argument.

Correlation Notes

• NBIS is the tightest public comp divergence is tradable both directions. CRWV was the weaker leg post-Q1; the 6/5 "CoreWeave vs. Nebius" piece and the joint 6/22 Nasdaq-100 inclusion now tie the two more tightly. Both joining the index together can compress the spread.
• IREN, Core Scientific lead within gpu-cloud-neoclouds; relative strength among the four is the cleanest theme-health gauge.
• NVDA is dual-linked supplier and ~47.2M-share holder. CRWV trades with NVDA sentiment and the broader AI-infra capex tape (the SpaceX/Google 110k-GPU deal is the demand proxy).
• Credit: the 9.750% 2031s, the new 2032 notes and the $850M data-center junk bond are the leading risk gauges; equity follows credit on this name, and the refi outcome is the swing variable.
• SpaceX IPO / AI-deal sentiment is a near-term beta driver for the whole high-beta AI-infrastructure complex through debut week.